Premium
Hot Features
Inscrivez-vous pour des alertes en temps réel, un portefeuille personnalisé et des mouvements de marché.
Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people wh... Virios Therapeutics Inc is a development-stage biotechnology company. It is focused on advancing novel antiviral therapies to treat diseases associated with a viral triggered abnormal immune response such as fibromyalgia. The company is engaged in the development of its product, IMC-1, for people who are suffering from fibromyalgia. Show more
| Période | Variation | Variation % | Ouver. | Haut | Bas | Moyenne Vol. Quot. | VWAP | |
|---|---|---|---|---|---|---|---|---|
| 1 | 0 | 0 | 3.875 | 3.875 | 3.875 | 0 | 0 | CS |
| 4 | 0 | 0 | 3.875 | 3.875 | 3.875 | 0 | 0 | CS |
| 12 | 0 | 0 | 3.875 | 3.875 | 3.875 | 0 | 0 | CS |
| 26 | -0.625 | -13.8888888889 | 4.5 | 5.17 | 3.15 | 397523 | 3.85275012 | CS |
| 52 | -7.15 | -64.8526077098 | 11.025 | 14.5 | 3.15 | 715041 | 5.37478661 | CS |
| 156 | -130.625 | -97.1189591078 | 134.5 | 227.7725 | 3.15 | 708736 | 16.66764824 | CS |
| 260 | -340.125 | -98.8735465116 | 344 | 359.75 | 3.15 | 535744 | 29.01959287 | CS |
| Aucune Discussion Trouvée |
| Ajouter une Discussion |
Les dernières valeurs consultées apparaîtront dans cette boîte, vous permettant de choisir facilement les titres vus auparavant.
Assistance: support@advfn.fr
En accédant aux services disponibles de ADVFN, vous acceptez les Conditions Générales de ADVFN Conditions Générales
